ChemoMetec A/S (CPH:CHEMM)
647.50
-4.50 (-0.69%)
Oct 15, 2025, 4:59 PM CET
ChemoMetec Revenue
In the fiscal year ending June 30, 2025, ChemoMetec had annual revenue of 495.57M DKK with 21.50% growth. ChemoMetec had revenue of 244.10M in the half year ending June 30, 2025, with 21.00% growth.
Revenue
495.57M
Revenue Growth
+21.50%
P/S Ratio
22.74
Revenue / Employee
2.92M
Employees
170
Market Cap
11.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 495.57M | 87.70M | 21.50% |
Jun 30, 2024 | 407.87M | -36.53M | -8.22% |
Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.87B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.86B |
H. Lundbeck | 23.52B |
Zealand Pharma | 9.11B |
Ambu A/S | 5.96B |
ChemoMetec News
- 8 months ago - Half Year 2025 Chemometec A/S Earnings Call Transcript - GuruFocus